On December 31. 2021, Omega Healthcare Investors, Inc. (the 'Company') and Mr. Steven J. Insoft, the Company's Chief Corporate Development Officer, mutually agreed that Mr. Insoft's employment with the Company will terminate effective January 1, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30.74 USD | +0.18% | -0.96% | +0.55% |
May. 09 | RBC Lifts Price Target on Omega Healthcare Investors to $32 From $31, Keeps Sector Perform Rating | MT |
May. 03 | Transcript : Omega Healthcare Investors, Inc., Q1 2024 Earnings Call, May 03, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.55% | 7.58B | |
+9.91% | 59.09B | |
-5.02% | 19.25B | |
-10.80% | 5.82B | |
+10.95% | 3.51B | |
+1.79% | 3.36B | |
-1.73% | 3.22B | |
+9.67% | 2.87B | |
+17.48% | 2.84B | |
-15.69% | 2.62B |
- Stock Market
- Equities
- OHI Stock
- News Omega Healthcare Investors, Inc.
- Omega Healthcare Investors, Inc. Terminates Steven J. Insoft as Chief Corporate Development Officer